The Burden Of Illness and Prevalence In Diffuse Large B-Cell (DLBCL) and Follicular (FL) Lymphomas

被引：4
|
作者：
Dulac, Edward J., III
Joy, Karen A.
Ndindjock, Roger
Coyle, Katharine B.
Wade, Rolin L.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.5619.5619
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5619
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Prognostic significance of BCL-6 expression in diffuse large B-cell lymphomas (DLBCL)
    Karikehalli, S
    Nazeer, T
    LABORATORY INVESTIGATION, 2002, 82 (01) : 246A - 246A
  • [22] Treatment of diffuse large B-cell lymphomas
    C. Zwick
    N. Murawski
    Michael Pfreundschuh
    memo - Magazine of European Medical Oncology, 2009, 2 (3) : 150 - 153
  • [23] Treatment of diffuse large B-cell lymphomas
    Zwick, C.
    Murawski, N.
    Pfreundschuh, M.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2009, 2 (03) : 150 - 153
  • [24] Treatment of Diffuse Large B-Cell Lymphomas
    Magomedova, Aminat U.
    Kravchenko, Sergey K.
    Kremenetskaya, Alexandra
    Zvonkov, Evgenyi
    Baryakh, Elena
    Mangasarova, Yana
    Kaplanskaya, Irina
    Samojlova, Rima
    Vorobjev, Ivan A.
    Obuchova, Tatjana
    Karagjuljan, Suren
    Klyasova, Galina
    Shulutko, Elena
    Galstyan, Gennadii
    Marjin, Dmitrii
    Gabeeva, Nelya
    Vorobjev, Andrey
    BLOOD, 2011, 118 (21) : 1153 - 1154
  • [25] Composite follicular (FL) and diffuse large B cell lymphoma (DLBCL): A gene expression profiling (GEP) study
    Farinha, P.
    Lee, M.
    Al-Tourah, A.
    Connors, J.
    Gascoyne, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 106 - 106
  • [26] Everolimus in diffuse large B-cell lymphomas
    Merli, Michele
    Ferrario, Andrea
    Maffioli, Margherita
    Arcaini, Luca
    Passamonti, Francesco
    FUTURE ONCOLOGY, 2015, 11 (03) : 373 - 383
  • [27] Treatment of diffuse large B-cell lymphomas
    Fisher, Richard I.
    SEMINARS IN HEMATOLOGY, 2006, 43 (04) : 205 - 206
  • [28] A phase II study of single agent mocetinostat, an oral isotype-selective histone deacetylase (HDAC) inhibitor, in patients with diffuse large cell B-cell (DLBCL) and follicular (FL) lymphomas
    Crump, Michael
    Andreadis, Charalambos
    Assouline, Sarit E.
    Rizzieri, David
    Copeland, Amanda
    Van Der Jagt, Richard H. C.
    Fox, Susan
    Reid, Gregory K.
    Besterman, Jeffrey M.
    Martell, Robert E.
    Younes, Anas
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas
    King, BE
    Chen, C
    Locker, J
    Kant, J
    Okuyama, K
    Falini, B
    Swerdlow, SH
    MODERN PATHOLOGY, 2000, 13 (11) : 1219 - 1231
  • [30] Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas
    Palacio, C
    Acebedo, G
    Navarrete, M
    Ruiz-Marcellán, C
    Sanchez, C
    Blanco, A
    López, A
    HAEMATOLOGICA, 2001, 86 (09) : 934 - 940
12345